Accordingly, dysregulation of the mTOR signaling pathway has been implicated in many human diseases, such as diabetes, cancer, obesity, and nervous system diseases [23,24]. This evidence concerns the gene MTOR and obesity due to melanocortin 4 receptor deficiency.